U.S. Drug Induced Ototoxicity Treatment Market Trends 2034: Advancements in Otoprotective Drugs and Audiological Monitoring Technologies
The United States remains the largest contributor to the North American market due to its high prevalence of hearing impairment associated with medication use, increasing adoption of cochlear implants and hearing aids, and strong focus on early diagnosis. The country’s robust research ecosystem, extensive clinical trial activities, and growing geriatric population continue to create...
0 Kommentare 0 Anteile 11 Ansichten 0 Vorschau